The Probeat Proton Beam Therapy System by Hitachi recently got the green light from the FDA. Probeat delivers a proton beam, which reportedly allows for the delivery of radiation with greater accuracy than conventional energies for treating localized tumors and other conditions. Probeat was installed at M. D. Anderson in Texas. “Proton therapy was a natural next step for the Division of Radiation Oncology at M. D. Anderson, which has a long history of moving the discipline forward,” said Dr. James Cox, processor and head of the Division of Radiation Oncology at M. D. Anderson.
If you enjoy this content, please share it with a colleague
Related Content
June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...
May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...
May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...
January 26, 2024 — P-Cure continues its quest to successfully usher in a new era of clinical treatment with proton ...
October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...
October 5, 2023 — A new study, led by radiation oncology physicists at Miami Cancer Institute, part of Baptist Health ...
May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...
April 3, 2023 — P-Cure announced clearance of its Adaptive Proton Therapy Solution by the FDA for sales in the USA. P ...
February 28, 2023 — Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating ...
February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...